Bayer faces fourth U.S. Roundup cancer trial in Monsanto’s hometown
(Reuters) – Bayer AG (BAYGn.DE) is set to face a fourth U.S. jury trial over allegations that its Roundup weed killer causes cancer, with four cancer patients in the hometown…
Bayer could be close to Roundup settlement, mediator says
FILE PHOTO: Logo and flags of Bayer AG are pictured outside a plant of the German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay (Reuters) –…
Bayer expects significant surge in number of U.S. glyphosate cases
FRANKFURT (Reuters) – Bayer expects the number of claims in the United States related to Roundup herbicide to have surged in the third quarter, as the German drugs and pesticides…
Bayer says October U.S. glyphosate trial delayed until February
FILE PHOTO: Logo and flags of Bayer AG are pictured outside a plant of the German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay/File Photo FRANKFURT…
Bayer says October U.S. glyphosate trial delayed until February
FILE PHOTO: Logo and flags of Bayer AG are pictured outside a plant of the German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay/File Photo FRANKFURT…
Inside drugmakers’ strategy to boost cancer medicines with ‘Lazarus effect’
(Reuters) – In the halls of MD Anderson Cancer Center, the drug Vitrakvi is known for having a “Lazarus effect” in some patients because it can reverse late-stage cancer that…
Bayer mediator dismisses report of $8 billion Roundup settlement
NEW YORK/FRANKFURT (Reuters) – Bayer AG has not offered to pay billions of dollars to settle claims in the United States related to the Roundup herbicide, mediator Ken Feinberg said,…
Bayer mediator dismisses report of $8 billion Roundup settlement
NEW YORK/FRANKFURT (Reuters) – Bayer AG has not offered to pay billions of dollars to settle claims in the United States related to the Roundup herbicide, mediator Ken Feinberg said,…
Bayer in frame to win first EU nod for high-precision cancer drug
(Reuters) – Europe’s drug regulator has recommended approving Bayer’s Vitrakvi, putting the medicine on track to become the first in Europe to tackle tumours with a specific genetic mutation regardless…
In Roundup case, U.S. judge cuts $2 billion verdict against Bayer to $86 million
(Reuters) – A California judge on Thursday reduced a $2 billion jury verdict, slashing the award for a couple who blamed Bayer AG’s glyphosate-based weed killer, Roundup, for their cancer…